All Announcements
Susan L. Shin Joins Weil as Complex Commercial Litigation Partner
Weil, Gotshal & Manges LLP announced that Susan L. Shin has joined the firm’s New York office as a partner. Ms. Shin is part of Weil’s national complex commercial litigation practice.
Read MoreWeil Advises Aterian Investment Partners in its Acquisition of Hain Pure Protein From the Hain Celestial Group, Inc.
Weil is advising Aterian Investment Partners in its acquisition of Hain Pure Protein from The Hain Celestial Group, Inc. Hain Pure Protein comprises the Empire Kosher, Kosher Valley and FreeBird poultry brands. Empire Kosher is the largest fresh kosher poultry provider in the United States. FreeBird is a leading specialized, certified organic and antibiotic-free chicken provider to the foodservice, retail and home-delivered meal channels. Financial terms of the transaction were not disclosed.
Read MoreWeil Advises Barclays on Financing for Parker Hannifin Corporation’s $3.7B Acquisition of LORD Corporation
Weil is representing Barclays in committed bridge financing to support the $3.675 billion pending acquisition by Parker Hannifin Corporation, a manufacturer of motion and control technologies and systems, of LORD Corporation, a developer, manufacturer and marketer of adhesives, coatings, motion management devices, and sensing technologies.
Read MoreWeil Launches New Philanthropic Initiative, Weil Legal Innovators Program
Weil, Gotshal & Manges LLP announced the launch of its new multi-pronged philanthropic initiative, the Weil Legal Innovators Program (WLI).
Read MoreAnne-Sophie Noury Joins Weil as Business Finance & Restructuring Partner in Paris
Weil, Gotshal & Manges LLP announced that Anne-Sophie Noury will join the firm as a business finance & restructuring partner.
Read MoreWeil Hosts 2019 Women’s History Month Alumnae Dinner
Weil hosted a Women’s History Month alumnae event, Board Membership: Getting There and Adding Value, in New York.
Read MoreWeil Advises Willis Towers Watson in Acquisition of TRANZACT
Weil is advising Willis Towers Watson in its pending up to $1.4 billion acquisition of TRANZACT. Willis Towers Watson is a global advisory, broking and solutions company and TRANZACT is a direct-to-consumer health care organization that links individuals to U.S. insurance carriers.
Read More